Orthocell has announced it has submitted an application to Health Canada for a Medical Devce Licence (MDL) to sell its leading nerve repair product Remplirâ„¢ into the US$75 million Canadian nerve repair market.
Health Canada is the regulatory authority responsible for regulating the importation, manufacture, export, and supply of medical devices.
Evaluation of Orthocell’s application is now in progress with clearance expected in the second half of 2025.